ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,362.53
0.10%
Dow Jones
39,056.39
0.44%
Gold vs US Dollar
2,312.495
0.19%
Brent Oil
83.725
0.20%
Bitcoin
61,498.21
0.51%
Pepperstone
Advertisement
Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Diffusion Pharmaceuticals Inc (DFFN)

  7. Diffusion Pharmaceuticals Inc (DFFN) News

Diffusion Pharmaceuticals (DFFN)

Diffusion Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DFFN
DateTimeSourceHeadlineSymbolCompany
29/04/202421:06Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DFFNDiffusion Pharmaceuticals Inc
23/04/202413:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
12/04/202400:55Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:DFFNDiffusion Pharmaceuticals Inc
05/04/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
04/04/202412:00Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
29/03/202420:02Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
28/03/202412:36Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
18/03/202420:32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
06/03/202421:05Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
05/03/202413:51Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
28/02/202422:02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
14/02/202414:23Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
09/02/202422:02Edgar (US Regulatory)Form SC 13D - General statement of acquisition of beneficial ownershipNASDAQ:DFFNDiffusion Pharmaceuticals Inc
09/02/202421:31Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
07/02/202421:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
02/02/202421:17Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
26/01/202423:47Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
26/01/202423:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
26/01/202423:46Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
26/01/202423:45Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
26/01/202423:44Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
26/01/202423:43Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
05/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
04/01/202421:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
21/12/202321:05Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
22/11/202321:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
17/11/202322:03Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DFFNDiffusion Pharmaceuticals Inc
13/11/202311:30Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DFFNDiffusion Pharmaceuticals Inc
10/11/202300:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
10/11/202300:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DFFNDiffusion Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DFFN

Your Recent History

LSE
ITV
Itv
LSE
GWMO
Great Western Mining
LSE
SYME
Supply@me Capital
LSE
FDEV
Frontier Developments
LSE
BIRD
Blackbird
LSE
KEFI
Kefi Gold And Copper
LSE
DEC
Diversified Energy
LSE
TERN
Tern
LSE
BOO
Boohoo
LSE
DGI
Dg Innovate
LSE
BARC
Barclays
LSE
SCE
Surface Transforms
LSE
SAR
Sareum
LSE
SYNT
Synthomer
LSE
ALBA
Alba Mineral Resources
LSE
TYM
Tertiary Minerals
Delayed Upgrade Clock
    ADVFN Logo

    United Kingdom
    Company
    Business
    Popular
    Get The App

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved